Girdhar Gaurav, Epstein Evan, Nguyen Kevin, Gregg Chelsea, Kumar Tejashri, Wainwright John, Liu Amon Y, Linfante Italo
Department of R&D, Neurovascular, Medtronic, Irvine, California, USA.
AYL Consulting LLC, Redwood City, California, USA.
Interv Neurol. 2020 Jan;8(2-6):187-195. doi: 10.1159/000499974. Epub 2019 Jun 18.
First pass success (FPS) can be defined as in vitro retrieval of clot in a single pass during mechanical thrombectomy (MT) for acute large vessel occlusion (LVO). Despite advancements in MT technology, retrieval of fibrin-rich clots remains a challenge. Therefore, the effect of stent retriever length on FPS for fibrin-rich clots was investigated by using Solitaire 6 × 40 versus 6 × 30 mm devices with a balloon guide catheter (BGC) or distal access catheter (DAC) and sheath, in an in vitro model of anterior circulation neurovascular anatomy. Additionally, vascular safety of the Solitaire 6 × 40 versus 6 × 30 mm devices was evaluated in a porcine model for differences in: luminal thrombus, inflammation, endothelial coverage, fibrin deposits, smooth muscle cell loss, elastic lamina and adventitia disruption, intimal hyperplasia, and lumen reduction, at 0, 30, and 90 days post-treatment. In vitro overall FPS was measured as: Solitaire 6 × 40 (95%) and Solitaire 6 × 30 (67%). FPS for clot location in middle cerebral artery was: (a) BGC (6 × 40 mm: 100%; 6 × 30 mm: 100%; = 8); (b) DAC with 088 sheath (6 × 40 mm: 83%; 6 × 30 mm: 33%; = 12). FPS for clot location in internal carotid artery was: (a) BGC (6 × 40 mm: 100%; 6 × 30 mm: 80%; = 11); (b) DAC with 088 sheath (6 × 40 mm: 100%; 6 × 30 mm: 67%; = 10). Stent length had a significant effect (Fisher's exact test; < 0.05) on FPS. In vivo evaluation in the porcine model showed no difference in vascular safety parameters between the Solitaire 6 × 40 and 6 × 30 mm devices ( > 0.05) at all time points in the study. Longer stent retrievers may be safe and effective in improving FPS for fibrin-rich clots in in vitro and in vivo models of LVO.
首次通过成功率(FPS)可定义为在急性大血管闭塞(LVO)的机械取栓术(MT)过程中单次通过体外取出血栓。尽管MT技术有所进步,但取出富含纤维蛋白的血栓仍然是一项挑战。因此,在体外前循环神经血管解剖模型中,使用6×40 mm与6×30 mm的Solitaire装置搭配球囊导引导管(BGC)或远端通路导管(DAC)及鞘管,研究了支架取栓器长度对富含纤维蛋白血栓的FPS的影响。此外,在猪模型中评估了6×40 mm与6×30 mm的Solitaire装置在治疗后0、30和90天时在以下方面的差异的血管安全性:腔内血栓、炎症、内皮覆盖、纤维蛋白沉积、平滑肌细胞丢失、弹性膜和外膜破坏、内膜增生以及管腔缩小。体外总体FPS测量结果为:6×40 mm的Solitaire(95%)和6×30 mm的Solitaire(67%)。大脑中动脉血栓位置的FPS为:(a)BGC(6×40 mm:100%;6×30 mm:100%;n = 8);(b)带088鞘管的DAC(6×40 mm:83%;6×30 mm:33%;n = 12)。颈内动脉血栓位置的FPS为:(a)BGC(6×40 mm:100%;6×30 mm:80%;n = 11);(b)带088鞘管的DAC(6×40 mm:100%;6×30 mm:67%;n = 10)。支架长度对FPS有显著影响(Fisher精确检验;P < 0.05)。在猪模型中的体内评估显示,在研究的所有时间点,6×40 mm与6×30 mm的Solitaire装置之间的血管安全性参数没有差异(P > 0.05)。在LVO的体外和体内模型中,更长的支架取栓器可能在提高富含纤维蛋白血栓的FPS方面是安全有效的。